New York Blood Center Enterprises
New York Blood Center Enterprises is a nonprofit blood collection and distribution organization serving New York and beyond.
Last updated October 29, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
New York Blood Center Enterprises (NYBCe) is a nonprofit organization that collects, tests, processes, and distributes blood and blood products. It is one of the largest community-based blood centers in the United States, supplying hospitals across New York, New Jersey, and Connecticut. The organization also conducts research in transfusion medicine and provides related services such as stem cell collection and tissue banking. NYBCe operates through a network of donor centers and mobile blood drives, and it works closely with hospitals and health systems to meet patient needs. As a nonprofit, it reinvests surplus into research, education, and community programs. The brand is known for its public health role and for its efforts to maintain a safe and adequate blood supply.
History
New York Blood Center Enterprises was founded in 1964 as a nonprofit blood center to serve the New York metropolitan area. Over the decades, it expanded its operations to become a major supplier of blood products to hospitals in the region. The organization has been involved in research breakthroughs, including work on hepatitis testing and blood safety. In recent years, NYBCe has broadened its services to include cellular therapy and regenerative medicine. It operates multiple donor centers and conducts thousands of mobile blood drives annually. The organization is known for its role in public health emergencies, including during the COVID-19 pandemic, when it managed convalescent plasma collection. NYBCe continues to invest in research and technology to improve transfusion outcomes.
- 2020
Managed convalescent plasma collection during COVID-19 pandemic
- 1964
Founded as a nonprofit blood center
Products and positioning
Nonprofit community blood center and research organization
Whole blood
Red blood cells
Platelets
Plasma
Recent events
New York Blood Center Enterprises appoints Meghan Delaney as next President and CEO[2]
Reported:
On October 12, 2026, the Board of Trustees of New York Blood Center Enterprises (NYBCe) announced the appointment of Meghan Delaney, DO, MPH, as the organization's next President and Chief Executive Officer following a national search. She will assume the role on January 4, 2027, succeeding Christopher D. Hillyer, MD, who has led NYBCe since 2009 and will transition to Special Advisor to the Board of Trustees.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/new-york-blood-center-enterprises-nybce · Editorial policy · How profiles are compiled